1. Home
  2. BZUN vs TTRX Comparison

BZUN vs TTRX Comparison

Compare BZUN & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Baozun Inc.

BZUN

Baozun Inc.

HOLD

Current Price

$2.81

Market Cap

159.3M

ML Signal

HOLD

Logo Turn Therapeutics Inc.

TTRX

Turn Therapeutics Inc.

N/A

Current Price

$7.78

Market Cap

281.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BZUN
TTRX
Founded
2007
2015
Country
China
United States
Employees
6762
2
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
159.3M
281.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BZUN
TTRX
Price
$2.81
$7.78
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$8.00
AVG Volume (30 Days)
237.4K
128.5K
Earning Date
05-20-2026
05-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$7.89
N/A
Revenue Next Year
$6.16
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.07
$2.57
52 Week High
$4.88
$11.69

Technical Indicators

Market Signals
Indicator
BZUN
TTRX
Relative Strength Index (RSI) 58.65 47.75
Support Level $2.61 $4.40
Resistance Level $2.82 $11.69
Average True Range (ATR) 0.12 1.04
MACD -0.01 -0.22
Stochastic Oscillator 75.49 4.52

Price Performance

Historical Comparison
BZUN
TTRX

About BZUN Baozun Inc.

Baozun Inc is engaged to provide its customers with end-to-end e-commerce solutions including the sales of apparel, home and electronic products, online store design and setup, visual merchandising and marketing, online store operations, customer services, warehousing and order fulfillment, as well as the holistic brand management, including tactic positioning, branding and marketing, retail and e-commerce operations, supply chain and logistics, and technology empowerment. It has two operating segments: E-Commerce (encompassing BEC and BZI) and Brand Management (representing BBM). The company generates maximum of its revenue from E-Commerce (encompassing BEC and BZI) segment.

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.

Share on Social Networks: